Biological Safety Testing Products & Services Market by Product (Instruments, Reagents & Kits, Services), Test Type (Adventitious Agent Detection Tests, Bioburden Tests, Cell Line Authentication & Characterization Tests), Application - Global Forecast 202

Biological Safety Testing Products & Services Market by Product (Instruments, Reagents & Kits, Services), Test Type (Adventitious Agent Detection Tests, Bioburden Tests, Cell Line Authentication & Characterization Tests), Application - Global Forecast 2023-2030


The Biological Safety Testing Products & Services Market is projected to reach USD 11.86 billion by 2030 from USD 5.09 billion in 2022, at a CAGR of 11.14% during the forecast period.

Market Segmentation & Coverage:

This research report analyzes various sub-markets, forecasts revenues, and examines emerging trends in each category to provide a comprehensive outlook on the Biological Safety Testing Products & Services Market.
  • Based on Product, market is studied across Instruments, Reagents & Kits, and Services. The Services is projected to witness significant market share during forecast period.
  • Based on Test Type, market is studied across Adventitious Agent Detection Tests, Bioburden Tests, Cell Line Authentication & Characterization Tests, Endotoxin Tests, Residual Host Contamination Detection Tests, and Sterility Tests. The Cell Line Authentication & Characterization Tests is projected to witness significant market share during forecast period.
  • Based on Application, market is studied across Blood & Blood-Based Products, Gene Therapy, Stem Cell, Tissue & Tissue-Based Products, and Vaccines & Therapeutics. The Blood & Blood-Based Products is projected to witness significant market share during forecast period.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.
Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is an indispensable tool for assessing the Biological Safety Testing Products & Services Market. It comprehensively evaluates vendors, analyzing key metrics related to Business Strategy and Product Satisfaction. This enables users to make informed decisions tailored to their specific needs. Through advanced analysis, vendors are categorized into four distinct quadrants, each representing a different level of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V). Be assured that this insightful framework empowers decision-makers to navigate the market with confidence.

Market Share Analysis:

The Market Share Analysis offers invaluable insights into the vendor landscape Biological Safety Testing Products & Services Market. By evaluating their impact on overall revenue, customer base, and other key metrics, we provide companies with a comprehensive understanding of their performance and the competitive environment they confront. This analysis also uncovers the level of competition in terms of market share acquisition, fragmentation, dominance, and industry consolidation during the study period.

Key Company Profiles:

The report delves into recent significant developments in the Biological Safety Testing Products & Services Market, highlighting leading vendors and their innovative profiles. These include Asahi Kasei Corporation, Avance Biosciences Inc., BBF Sterilisationsservice GmbH, BSL Bioservice Scientific Laboratories Munich GmbH, Charles River Laboratories International, Inc., Creative Biogene, Eurofins Scientific SE, Labquality Oy, Lonza Group AG, Merck KGaA, North American Science Associates, Inc., North American Science Associates, LLC, NuAire, Inc., Pace Analytical Services, LLC, Samsung Biologics, Sartorius AG, SGS Société Générale de Surveillance SA, Thermo Fisher Scientific Inc., Toyobo Co., Ltd., UL LLC, ViruSure GmbH, and WuXi Biologics Co., Ltd..

The report offers valuable insights on the following aspects:
  1. Market Penetration: It provides comprehensive information about key players' market dynamics and offerings.
  2. Market Development: In-depth analysis of emerging markets and penetration across mature market segments, highlighting lucrative opportunities.
  3. Market Diversification: Detailed information about new product launches, untapped geographies, recent developments, and investments.
  4. Competitive Assessment & Intelligence: Exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of leading players.
  5. Product Development & Innovation: Intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
  1. What is the market size and forecast for the Biological Safety Testing Products & Services Market?
  2. Which products, segments, applications, and areas hold the highest investment potential in the Biological Safety Testing Products & Services Market?
  3. What is the competitive strategic window for identifying opportunities in the Biological Safety Testing Products & Services Market?
  4. What are the latest technology trends and regulatory frameworks in the Biological Safety Testing Products & Services Market?
  5. What is the market share of the leading vendors in the Biological Safety Testing Products & Services Market?
  6. Which modes and strategic moves are suitable for entering the Biological Safety Testing Products & Services Market?


Note: PDF & Excel + Online Access - 1 Year


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Biological Safety Testing Products & Services Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing incidences of chronic diseases with changing lifestyle globally
5.1.1.2. Government intervention in adoption of good manufacturing practices during drug development
5.1.1.3. Increasing development and commercialization of drugs
5.1.2. Restraints
5.1.2.1. Lack of skilled professionals for biological safety testing
5.1.3. Opportunities
5.1.3.1. Research and development in tissue cultures and viral safety testing
5.1.3.2. Growing outsourcing of testing services to specialized service providers
5.1.4. Challenges
5.1.4.1. Concerns regarding strict regulations and complex procedures
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of COVID-19
5.5. Cumulative Impact of Russia-Ukraine Conflict
5.6. Cumulative Impact of High Inflation
5.7. Porter’s Five Forces Analysis
5.7.1. Threat of New Entrants
5.7.2. Threat of Substitutes
5.7.3. Bargaining Power of Customers
5.7.4. Bargaining Power of Suppliers
5.7.5. Industry Rivalry
5.8. Value Chain & Critical Path Analysis
5.9. Regulatory Framework
5.10. Client Customization
6. Biological Safety Testing Products & Services Market, by Product
6.1. Introduction
6.2. Instruments
6.3. Reagents & Kits
6.4. Services
7. Biological Safety Testing Products & Services Market, by Test Type
7.1. Introduction
7.2. Adventitious Agent Detection Tests
7.3. Bioburden Tests
7.4. Cell Line Authentication & Characterization Tests
7.5. Endotoxin Tests
7.6. Residual Host Contamination Detection Tests
7.7. Sterility Tests
8. Biological Safety Testing Products & Services Market, by Application
8.1. Introduction
8.2. Blood & Blood-Based Products
8.3. Gene Therapy
8.4. Stem Cell
8.5. Tissue & Tissue-Based Products
8.6. Vaccines & Therapeutics
9. Americas Biological Safety Testing Products & Services Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Biological Safety Testing Products & Services Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Biological Safety Testing Products & Services Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. Asahi Kasei Corporation
13.1.2. Avance Biosciences Inc.
13.1.3. BBF Sterilisationsservice GmbH
13.1.4. BSL Bioservice Scientific Laboratories Munich GmbH
13.1.5. Charles River Laboratories International, Inc.
13.1.6. Creative Biogene
13.1.7. Eurofins Scientific SE
13.1.8. Labquality Oy
13.1.9. Lonza Group AG
13.1.10. Merck KGaA
13.1.11. North American Science Associates, Inc.
13.1.12. North American Science Associates, LLC
13.1.13. NuAire, Inc.
13.1.14. Pace Analytical Services, LLC
13.1.15. Samsung Biologics
13.1.16. Sartorius AG
13.1.17. SGS Société Générale de Surveillance SA
13.1.18. Thermo Fisher Scientific Inc.
13.1.19. Toyobo Co., Ltd.
13.1.20. UL LLC
13.1.21. ViruSure GmbH
13.1.22. WuXi Biologics Co., Ltd.
13.2. Key Product Portfolio
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings